X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteoporosis (443) 443
humans (374) 374
index medicus (320) 320
female (282) 282
endocrinology & metabolism (253) 253
postmenopausal women (216) 216
bisphosphonates (173) 173
antiresorptive agents (169) 169
aged (145) 145
alendronate (144) 144
animals (144) 144
bone density conservation agents - therapeutic use (144) 144
fractures (138) 138
bone density - drug effects (135) 135
bone-mineral density (133) 133
antiresorptive therapy (132) 132
middle aged (123) 123
zoledronic acid (121) 121
antiresorptives (116) 116
denosumab (113) 113
bones (112) 112
orthopedics (110) 110
bone density (106) 106
bone mineral density (105) 105
osteoporosis - drug therapy (105) 105
male (104) 104
osteoporosis, postmenopausal - drug therapy (96) 96
postmenopausal osteoporosis (96) 96
vertebral fractures (96) 96
antiresorptive (94) 94
diphosphonates - therapeutic use (91) 91
women (89) 89
density (81) 81
medicine & public health (79) 79
risk factors (76) 76
prevention (73) 73
teriparatide (73) 73
therapy (72) 72
risk (69) 69
parathyroid-hormone (68) 68
aged, 80 and over (67) 67
bisphosphonate (67) 67
care and treatment (67) 67
bone (63) 63
parathyroid hormone (63) 63
analysis (62) 62
drug therapy (62) 62
mineral density (62) 62
antiresorptive drugs (61) 61
nonvertebral fractures (61) 61
health aspects (60) 60
risedronate (59) 59
pharmacology & pharmacy (57) 57
treatment outcome (57) 57
rheumatology (56) 56
cortical bone (55) 55
fracture (55) 55
randomized-trial (54) 54
bone resorption (53) 53
endocrinology (53) 53
rats (53) 53
bone density conservation agents - adverse effects (52) 52
bone density conservation agents - pharmacology (52) 52
osteonecrosis (51) 51
research (51) 51
fractures, bone - prevention & control (49) 49
bone density conservation agents - administration & dosage (48) 48
bone and bones - drug effects (47) 47
bone remodeling - drug effects (44) 44
double-blind (44) 44
medicine, general & internal (44) 44
ovariectomy (44) 44
biochemical markers (43) 43
bone turnover (42) 42
dentistry (42) 42
hip fracture (42) 42
antiresorptive treatment (40) 40
trabecular bone (40) 40
vitamin d (40) 40
bisphosphonate-related osteonecrosis (39) 39
dentistry, oral surgery & medicine (39) 39
femur (39) 39
turnover (39) 39
bone resorption - drug therapy (38) 38
jaw (38) 38
surgery (38) 38
diphosphonates - pharmacology (37) 37
mass (37) 37
bone remodeling (36) 36
osteoclasts (36) 36
clinical trials (35) 35
estrogen (35) 35
hip (35) 35
bone strength (34) 34
osteoclasts - drug effects (34) 34
phosphonates (34) 34
strontium ranelate (34) 34
adult (33) 33
diphosphonates - administration & dosage (33) 33
hormone replacement therapy (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (694) 694
German (24) 24
Spanish (9) 9
French (8) 8
Japanese (5) 5
Turkish (4) 4
Czech (2) 2
Hungarian (2) 2
Russian (2) 2
Croatian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Synlett, ISSN 0936-5214, 06/2012, Volume 23, Issue 10, pp. 1523 - 1525
Abstract A series of pentyl-sulfonyl amidines was obtained using a multicomponent synthesis process. The rearrangement of unstable... 
letter | diazoalkane | antiresorptive agent | sulfonyl amidines | multicomponent reaction | amino acids | TRIAZOLINES | CHEMISTRY, ORGANIC
Journal Article
Quintessence International, ISSN 0033-6572, 2019, Volume 50, Issue 1, pp. 40 - 48
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 2014, Volume 29, Issue 1, pp. 260 - 267
Journal Article
RADIOLOGE, ISSN 0033-832X, 10/2018, Volume 58, Issue 10, pp. 935 - 948
Drug-induced osteonecrosis of the jaw represents a relatively new, multifactor-induced disease. Diseases with increased bone resorption are widely treated with... 
Early detection of disease | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | Jaw diseases | Imaging | Determination of extent | Antiresorptive drugs | TREATED PATIENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 08/2004, Volume 19, Issue 8, pp. 1250 - 1258
Journal Article
The Lancet, ISSN 0140-6736, 09/2017, Volume 390, Issue 10102, pp. 1565 - 1566
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)31824-X Byline: Juliet Compston (a) 
MEDICINE, GENERAL & INTERNAL | MINERAL DENSITY | ANTIRESORPTIVE THERAPY | TERIPARATIDE TREATMENT | ROMOSOZUMAB | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Phosphonates | Osteoporosis | Bones | Bone density | Drug therapy | Bisphosphonates
Journal Article
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, ISSN 0884-0431, 9/2012, Volume 27, Issue 9, pp. 1927 - 1935
Resorption cavities formed during bone remodeling may act as “stress risers” and impair cancellous bone strength, but biomechanical analyses of the effects of... 
antiresorptive | bone quality | finite element analysis | bone strength | resorption cavities
Journal Article
Medical Journal Armed Forces India, ISSN 0377-1237, 01/2015, Volume 71, Issue 1, pp. 71 - 75
Bone remodeling is the continuous process by which old bone is removed by bone-resorbing cells, the osteoclasts and replaced by new bone synthesized by bone... 
Osteoporosis | Giant cell tumor | Antiresorptive | Short Communication
Journal Article
Journal Article
Journal Article
Osteoporosis International, ISSN 0937-941X, 1/2008, Volume 19, Issue 1, pp. 87 - 94
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, p. 21072
Journal Article